Litcius/Paper detail

NEAT 1 knockdown enhances the sensitivity of human non-small-cell lung cancer cells to anlotinib

Guoqing Gu, Chenxi Hu, Kaiyuan Hui, Ting Chen, Huiqin Zhang, Xiaodong Jiang

2021Aging22 citationsDOIOpen Access PDF

Abstract

. Thus, combined treatment of anlotinib with NEAT 1 knockdown may provide a new combined therapeutic approach for NSCLC patients.

Topics & Concepts

Gene knockdownDownregulation and upregulationCancer researchCell growthApoptosisWnt signaling pathwayChemistryFlow cytometryIn vivoCell biologyBiologySignal transductionMolecular biologyBiochemistryGeneBiotechnologyCancer-related molecular mechanisms researchRNA modifications and cancerLung Cancer Research Studies
NEAT 1 knockdown enhances the sensitivity of human non-small-cell lung cancer cells to anlotinib | Litcius